BGMS director sells 88,204 shares at $4.217

Bio Green Med Solution (BGMS) insider activity: Reporting person Kua Khai Loon, a director, filed a Form 4 disclosing open-market sales of BGMS common stock.

Accepted by SEC EDGAR 10/20/2025 - 06:00 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Bio Green Med Solution (BGMS) insider activity: Reporting person Kua Khai Loon, a director, filed a Form 4 disclosing open-market sales of BGMS common stock. On 10/15/2025, 7,479 shares were sold at $5.661, leaving 330,681 shares beneficially owned. On 10/16/2025, 88,204 shares were sold at $4.217, leaving 242,477 shares beneficially owned. Ownership is listed as Direct. The filing was made by one reporting person.

Insider Trade Summary

Net Seller: 95,683 shares

Net Sell 2 txns

Insider Kua Khai Loon

Role 10% Owner

Sold 95,683 shs ($414K)

Type	Security	Shares	Price	Value
Sale	Common Stock	88,204	$4.217	$372K
Sale	Common Stock	7,479	$5.661	$42K

Holdings After Transaction: Common Stock — 242,477 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did BGMS report on Form 4?

Director Kua Khai Loon reported selling 7,479 shares at $5.661 on 10/15/2025 and 88,204 shares at $4.217 on 10/16/2025.

How many BGMS shares did the insider hold after the transactions?

After the 10/15/2025 sale, holdings were 330,681 shares; after the 10/16/2025 sale, holdings were 242,477 shares.

What is the insider’s relationship to BGMS?

The reporting person is a Director of Bio Green Med Solution, Inc.

Was the ownership listed as direct or indirect?

Ownership was reported as Direct.

How many individuals filed this BGMS Form 4?

It was filed by one reporting person.

What were the sale prices reported on the BGMS Form 4?

Reported prices were $5.661 on 10/15/2025 and $4.217 on 10/16/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kua Khai Loon

(Last) (First) (Middle)

NO 28 JALAN EKOFLORA 1/13 TAMAN EKOFLORA

(Street)

JOHOR BAHRU N8 81100

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bio Green Med Solution, Inc. [ BGMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		S		7,479	D	$5.661	330,681	D
Common Stock	10/16/2025		S		88,204	D	$4.217	242,477	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Kua Khai Loon	10/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.